Common Stock, Shares, Outstanding of MYRIAD GENETICS INC from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
MYRIAD GENETICS INC quarterly Common Stock, Shares, Outstanding history and change rate from Q2 2010 to Q3 2025.
  • MYRIAD GENETICS INC Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 93,100,000, a 2.3% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

MYRIAD GENETICS INC Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 93,100,000 +2,100,000 +2.3% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 93,100,000 +2,200,000 +2.4% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 92,200,000 +1,700,000 +1.9% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 91,300,000 +1,400,000 +1.6% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 91,000,000 +8,900,000 +11% 30 Sep 2024 10-Q 04 Nov 2025 2025 Q3
Q2 2024 90,900,000 +9,000,000 +11% 30 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 90,500,000 +9,000,000 +11% 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q4 2023 89,900,000 +8,700,000 +11% 31 Dec 2023 10-Q 04 Nov 2025 2025 Q3
Q3 2023 82,100,000 +1,200,000 +1.5% 30 Sep 2023 10-Q 08 Nov 2024 2024 Q3
Q2 2023 81,900,000 +1,300,000 +1.6% 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 81,500,000 +1,200,000 +1.5% 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q4 2022 81,200,000 +1,200,000 +1.5% 31 Dec 2022 10-K 28 Feb 2025 2024 FY
Q3 2022 80,900,000 +1,200,000 +1.5% 30 Sep 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 80,600,000 +2,900,000 +3.7% 30 Jun 2022 10-Q 04 Aug 2023 2023 Q2
Q1 2022 80,300,000 +3,600,000 +4.7% 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 80,000,000 +4,600,000 +6.1% 31 Dec 2021 10-K 28 Feb 2025 2024 FY
Q3 2021 79,700,000 +4,500,000 +6% 30 Sep 2021 10-Q 02 Nov 2022 2022 Q3
Q2 2021 77,700,000 +3,000,000 +4% 30 Jun 2021 10-Q 05 Aug 2022 2022 Q2
Q1 2021 76,700,000 +2,200,000 +3% 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q4 2020 75,400,000 +900,000 +1.2% 31 Dec 2020 10-K 28 Feb 2024 2023 FY
Q3 2020 75,200,000 +800,000 +1.1% 30 Sep 2020 10-Q 04 Nov 2021 2021 Q3
Q2 2020 74,700,000 +1,200,000 +1.6% 30 Jun 2020 10-K 01 Mar 2023 2022 FY
Q1 2020 74,500,000 +1,100,000 +1.5% 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q4 2019 74,500,000 +1,300,000 +1.8% 31 Dec 2019 10-Q 04 Nov 2021 2021 Q3
Q3 2019 74,400,000 -300,000 -0.4% 30 Sep 2019 10-Q 06 Nov 2019 2020 Q1
Q2 2019 73,500,000 +2,900,000 +4.1% 30 Jun 2019 10-K 01 Mar 2023 2022 FY
Q1 2019 73,400,000 +3,500,000 +5% 31 Mar 2019 10-Q 08 May 2019 2019 Q3
Q4 2018 73,200,000 +3,800,000 +5.5% 31 Dec 2018 10-Q 06 Feb 2019 2019 Q2
Q3 2018 74,700,000 +5,500,000 +7.9% 30 Sep 2018 10-Q 07 Nov 2018 2019 Q1
Q2 2018 70,600,000 +2,200,000 +3.2% 30 Jun 2018 10-K 25 Feb 2022 2021 FY
Q1 2018 69,900,000 +1,800,000 +2.6% 31 Mar 2018 10-Q 09 May 2018 2018 Q3
Q4 2017 69,400,000 +1,300,000 +1.9% 31 Dec 2017 10-Q 07 Feb 2018 2018 Q2
Q3 2017 69,200,000 +800,000 +1.2% 30 Sep 2017 10-Q 08 Nov 2017 2018 Q1
Q2 2017 68,400,000 -700,000 -1% 30 Jun 2017 10-KT 16 Mar 2021 2020 FY
Q1 2017 68,100,000 -2,300,000 -3.3% 31 Mar 2017 10-Q 03 May 2017 2017 Q3
Q4 2016 68,100,000 -3,500,000 -4.9% 31 Dec 2016 10-Q 07 Feb 2018 2018 Q2
Q3 2016 68,400,000 -1,000,000 -1.4% 30 Sep 2016 10-Q 08 Nov 2017 2018 Q1
Q2 2016 69,100,000 +200,000 +0.29% 30 Jun 2016 10-K 13 Aug 2019 2019 FY
Q1 2016 70,400,000 +400,000 +0.57% 31 Mar 2016 10-Q 03 May 2017 2017 Q3
Q4 2015 71,600,000 +100,000 +0.14% 31 Dec 2015 10-Q 08 Feb 2017 2017 Q2
Q3 2015 69,400,000 -3,600,000 -4.9% 30 Sep 2015 10-Q 02 Nov 2016 2017 Q1
Q2 2015 68,900,000 -4,600,000 -6.3% 30 Jun 2015 10-K 24 Aug 2018 2018 FY
Q1 2015 70,000,000 -4,513,000 -6.1% 31 Mar 2015 10-Q 04 May 2016 2016 Q3
Q4 2014 71,500,000 -2,474,000 -3.3% 31 Dec 2014 10-Q 03 Feb 2016 2016 Q2
Q3 2014 73,000,000 -3,815,000 -5% 30 Sep 2014 10-Q 04 Nov 2015 2016 Q1
Q2 2014 73,500,000 -7,100,000 -8.8% 30 Jun 2014 10-K 09 Aug 2017 2017 FY
Q1 2014 74,513,000 -5,303,000 -6.6% 31 Mar 2014 10-Q 07 May 2014 2014 Q3
Q4 2013 73,974,000 -7,331,000 -9% 31 Dec 2013 10-Q 05 Feb 2014 2014 Q2
Q3 2013 76,815,000 -4,582,000 -5.6% 30 Sep 2013 10-Q 12 Nov 2013 2014 Q1
Q2 2013 80,600,000 -2,000,000 -2.4% 30 Jun 2013 10-K 10 Aug 2016 2016 FY
Q1 2013 79,816,000 -4,728,000 -5.6% 31 Mar 2013 10-Q 08 May 2013 2013 Q3
Q4 2012 81,305,000 -2,927,000 -3.5% 31 Dec 2012 10-Q 06 Feb 2013 2013 Q2
Q3 2012 81,397,000 -3,233,000 -3.8% 30 Sep 2012 10-Q 09 Nov 2012 2013 Q1
Q2 2012 82,600,000 -3,644,000 -4.2% 30 Jun 2012 10-K 12 Aug 2015 2015 FY
Q1 2012 84,544,000 -1,172,000 -1.4% 31 Mar 2012 10-Q 02 May 2012 2012 Q3
Q4 2011 84,232,000 -5,906,000 -6.6% 31 Dec 2011 10-Q 01 Feb 2012 2012 Q2
Q3 2011 84,630,000 -7,725,000 -8.4% 30 Sep 2011 10-Q 02 Nov 2011 2012 Q1
Q2 2011 86,244,000 -7,802,000 -8.3% 30 Jun 2011 10-K 15 Aug 2012 2012 FY
Q1 2011 85,716,000 31 Mar 2011 10-Q 04 May 2011 2011 Q3
Q4 2010 90,138,000 31 Dec 2010 10-Q 01 Feb 2011 2011 Q2
Q3 2010 92,355,000 30 Sep 2010 10-Q 03 Nov 2010 2011 Q1
Q2 2010 94,046,000 30 Jun 2010 10-K 15 Aug 2011 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.